negative regulation of insulin receptor signaling pathway

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. [GOC:bf]

The negative regulation of insulin receptor signaling pathway is a complex process that involves multiple mechanisms to fine-tune insulin sensitivity and prevent excessive signaling. This regulation is crucial for maintaining glucose homeostasis and preventing metabolic disorders such as type 2 diabetes. Here’s a detailed description of key players and mechanisms involved:

**1. Insulin Receptor Kinase Activity Regulation:**

* **Tyrosine Phosphatases (PTPs):** These enzymes dephosphorylate tyrosine residues on the insulin receptor, inhibiting its kinase activity. Examples include PTP1B, SHP-2, and LAR.
* **Protein Tyrosine Kinase (PTK) Inhibitors:** Some PTKs, like Src kinases, can negatively regulate the insulin receptor by directly inhibiting its phosphorylation.
* **Adaptor Proteins:** Proteins like Grb10 and Gab1 can act as negative regulators by competing with insulin receptor substrates (IRS) for binding sites, thus preventing the activation of downstream signaling cascades.
* **Ubiquitination and Degradation:** The insulin receptor can be ubiquitinated, leading to its internalization and degradation, thus reducing its signaling capacity.

**2. Downstream Signaling Pathway Inhibition:**

* **Phosphatidylinositol 3-Kinase (PI3K) Inhibition:** Proteins like PTEN (phosphatase and tensin homolog) dephosphorylate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which is a critical second messenger in the PI3K pathway.
* **Akt (Protein Kinase B) Inhibition:** Negative regulators like PHLPP (PH domain leucine-rich protein phosphatase) and PP2A (protein phosphatase 2A) dephosphorylate and inactivate Akt, a key downstream effector in insulin signaling.
* **mTOR Inhibition:** The mammalian target of rapamycin (mTOR) pathway, which is regulated by insulin, can be inhibited by various factors, including AMPK (AMP-activated protein kinase), which promotes catabolism and reduces mTOR activity.

**3. Feedback Mechanisms:**

* **IRS Phosphorylation:** Insulin signaling itself can lead to the phosphorylation of IRS proteins on serine/threonine residues, which can impair their ability to interact with the insulin receptor and activate downstream signaling.
* **Negative Feedback Loops:** Downstream signaling components can feed back to inhibit upstream components. For example, Akt can phosphorylate and inhibit IRS1, creating a negative feedback loop.

**4. Other Regulatory Mechanisms:**

* **Endoplasmic Reticulum (ER) Stress:** ER stress can disrupt insulin signaling by altering the expression and activity of key signaling proteins.
* **Inflammation:** Inflammation can lead to insulin resistance by activating pathways that inhibit insulin signaling and promote glucose production.
* **Hormonal Influences:** Hormones like glucagon and growth hormone can antagonize insulin signaling.

**5. Genetic Factors:**

* **Single Nucleotide Polymorphisms (SNPs):** Variations in genes involved in insulin signaling can influence the sensitivity to insulin.
* **Mutations:** Mutations in genes encoding key insulin signaling proteins can lead to disorders like type 2 diabetes.

Overall, the negative regulation of insulin receptor signaling pathway ensures a fine balance between insulin sensitivity and metabolic homeostasis. Disruptions in these regulatory mechanisms can lead to insulin resistance and metabolic disorders. Understanding these complex processes is crucial for developing strategies to treat and prevent these conditions.'
"

Proteins (21)

Compounds (713)